Lakefront Biotherapeutics NV Operating Expenses Growth & History (LKFT)
Lakefront Biotherapeutics NV's operating expenses was €787.5M for fiscal 2025.
View full Lakefront Biotherapeutics NV company overviewLakefront Biotherapeutics NV annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €787.5M | €358.3M | +83.51% |
| 2024 | 2024-12-31 | €429.1M | €101.1M | +30.84% |
| 2023 | 2023-12-31 | €328.0M | −€32.2M | −8.95% |
| 2022 | 2022-12-31 | €360.2M | −€44.1M | −10.91% |
| 2021 | 2021-12-31 | €404.3M | −€304.6M | −42.96% |
| 2020 | 2020-12-31 | €708.9M | €191.8M | +37.10% |
| 2019 | 2019-12-31 | €517.0M | €162.3M | +45.75% |
| 2018 | 2018-12-31 | €354.7M | €109.0M | +44.37% |
| 2017 | 2017-12-31 | €245.7M | €82.6M | +50.65% |
| 2016 | 2016-12-31 | €163.1M | €13.1M | +8.72% |
| 2015 | 2015-12-31 | €150.0M | — | — |
Lakefront Biotherapeutics NV quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €46.5M | −€71.1M | −60.48% |
| Q1 2026 | 2026-03-31 | €65.4M | −€154.6M | −70.27% |
| Q4 2025 | 2025-12-31 | €141.6M | — | — |
| Q3 2025 | 2025-09-30 | €102.0M | — | — |
| Q2 2025 | 2025-06-30 | €117.6M | — | — |
| Q1 2025 | 2025-03-31 | €220.0M | — | — |
| Q2 2021 | 2021-06-30 | €199.8M | −€2.0M | −0.99% |
| Q2 2020 | 2020-06-30 | €201.8M | €89.9M | +80.26% |
| Q2 2019 | 2019-06-30 | €112.0M | €21.2M | +23.32% |
| Q2 2018 | 2018-06-30 | €90.8M | €35.9M | +65.53% |
| Q2 2017 | 2017-06-30 | €54.8M | — | — |
Lakefront Biotherapeutics NV operating expenses trends
Over the last five fiscal years, Lakefront Biotherapeutics NV's operating expenses increased from €708.9M to €787.5M, a change of €78.6M. The latest reported quarter, Q2 2026, shows €46.5M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lakefront Biotherapeutics NV source filings ↗